Literature DB >> 25238941

Estimation of biomarker distributions using laboratory data collected during routine delivery of medical care.

Maurice Alan Brookhart1, Jonathan V Todd2, Xiaojuan Li2, B Diane Reams3, Virginia Pate2, Abhijit V Kshirsagar4.   

Abstract

PURPOSE: To examine the extent to which commonly ordered laboratory values obtained from large health care databases are representative of the distribution of laboratory values from the general population as reflected in the National Health and Nutrition Examination Survey.
METHODS: Means of test values from commercial insurance laboratory data and National Health and Nutrition Examination Survey data were compared. Inverse probability of selection weighting was used to account for possible selection bias and to create comparability between the two data sources.
RESULTS: The average values of most of the laboratory results from routine care were very close to their population means as estimated from NHANES. Tests that were more selectively ordered tended to differ. The inverse probability of selection weighting approach generally had a small effect on the estimated means but did improve estimation of some of the more selected tests.
CONCLUSIONS: Commonly ordered laboratory tests appear to be representative of values from the underlying population. This suggests that trends and other patterns in biomarker levels in the population may be reasonably studied using data collected during the routine delivery of medical care.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Epidemiologic methods; Laboratories; National Health and Nutrition Examination Survey; Selection bias

Mesh:

Substances:

Year:  2014        PMID: 25238941      PMCID: PMC4476533          DOI: 10.1016/j.annepidem.2014.07.013

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  10 in total

1.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

Review 2.  Multiple imputation in health-care databases: an overview and some applications.

Authors:  D B Rubin; N Schenker
Journal:  Stat Med       Date:  1991-04       Impact factor: 2.373

Review 3.  A review of uses of health care utilization databases for epidemiologic research on therapeutics.

Authors:  Sebastian Schneeweiss; Jerry Avorn
Journal:  J Clin Epidemiol       Date:  2005-04       Impact factor: 6.437

4.  Doubly robust estimation in missing data and causal inference models.

Authors:  Heejung Bang; James M Robins
Journal:  Biometrics       Date:  2005-12       Impact factor: 2.571

5.  Very large database of lipids: rationale and design.

Authors:  Seth S Martin; Michael J Blaha; Peter P Toth; Parag H Joshi; John W McEvoy; Haitham M Ahmed; Mohamed B Elshazly; Kristopher J Swiger; Erin D Michos; Peter O Kwiterovich; Krishnaji R Kulkarni; Joseph Chimera; Christopher P Cannon; Roger S Blumenthal; Steven R Jones
Journal:  Clin Cardiol       Date:  2013-10-01       Impact factor: 2.882

6.  ACCF/AHA/AMA-PCPI 2011 performance measures for adults with coronary artery disease and hypertension: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association-Physician Consortium for Performance Improvement.

Authors:  Joseph Drozda; Joseph V Messer; John Spertus; Bruce Abramowitz; Karen Alexander; Craig T Beam; Robert O Bonow; Jill S Burkiewicz; Michael Crouch; David C Goff; Richard Hellman; Thomas James; Marjorie L King; Edison A Machado; Eduardo Ortiz; Michael O'Toole; Stephen D Persell; Jesse M Pines; Frank J Rybicki; Lawrence B Sadwin; Joanna D Sikkema; Peter K Smith; Patrick J Torcson; John B Wong
Journal:  Circulation       Date:  2011-06-13       Impact factor: 29.690

Review 7.  Chronic kidney disease.

Authors:  Andrew S Levey; Josef Coresh
Journal:  Lancet       Date:  2011-08-15       Impact factor: 79.321

8.  Friedewald-estimated versus directly measured low-density lipoprotein cholesterol and treatment implications.

Authors:  Seth S Martin; Michael J Blaha; Mohamed B Elshazly; Eliot A Brinton; Peter P Toth; John W McEvoy; Parag H Joshi; Krishnaji R Kulkarni; Patrick D Mize; Peter O Kwiterovich; Andrew P Defilippis; Roger S Blumenthal; Steven R Jones
Journal:  J Am Coll Cardiol       Date:  2013-03-21       Impact factor: 24.094

9.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

10.  High-dimensional propensity score adjustment in studies of treatment effects using health care claims data.

Authors:  Sebastian Schneeweiss; Jeremy A Rassen; Robert J Glynn; Jerry Avorn; Helen Mogun; M Alan Brookhart
Journal:  Epidemiology       Date:  2009-07       Impact factor: 4.822

  10 in total
  2 in total

1.  Use of Linked Databases for Improved Confounding Control: Considerations for Potential Selection Bias.

Authors:  Jenny W Sun; Rui Wang; Dongdong Li; Sengwee Toh
Journal:  Am J Epidemiol       Date:  2022-03-24       Impact factor: 5.363

2.  Lipid treatment and goal attainment characteristics among persons with atherosclerotic cardiovascular disease in the United States.

Authors:  Alexa C Klimchak; Miraj Y Patel; Şerban R Iorga; Natasha Kulkarni; Nathan D Wong
Journal:  Am J Prev Cardiol       Date:  2020-05-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.